Wyeth Sues Nostrum Pharmaceuticals
- April 26, 2011
Wyeth files suit against Nostrum Pharmaceuticals over three patents related to an extended release formulation of venlafaxine hydrochloride. 4/21, District of New Jersey, 3:2011cv02280.
Access to the full article is currently available to RPX members only. Please contact us if you need further information.